Concord Biotech Limited (CONCORDBIO) — Net Asset Momentum
Concord Biotech Limited (CONCORDBIO) recorded a net asset momentum of 18.7% as of March 2025, with net assets of Rs18.13 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Concord Biotech Limited net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Concord Biotech Limited Net Asset Momentum (2020–2025)
This chart tracks Concord Biotech Limited's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is +18.7%, with net assets of Rs18.13 Billion INR as of March 2025. For live market cap and overall valuation, see CONCORDBIO market cap.
Annual Net Asset History for Concord Biotech Limited (2020–2025)
The table below shows the complete annual net asset history for Concord Biotech Limited from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Concord Biotech Limited tangible book value ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Rs18.13 Billion | Rs20.34 Billion | Rs2.22 Billion | ▲ +18.7% |
| 2024 | Rs15.27 Billion | Rs17.01 Billion | Rs1.74 Billion | ▲ +18.3% |
| 2023 | Rs12.90 Billion | Rs15.14 Billion | Rs2.24 Billion | ▲ +16.9% |
| 2022 | Rs11.03 Billion | Rs13.13 Billion | Rs2.10 Billion | ▲ +10.4% |
| 2021 | Rs9.99 Billion | Rs11.83 Billion | Rs1.83 Billion | ▲ +29.7% |
| 2020 | Rs7.70 Billion | Rs9.41 Billion | Rs1.70 Billion | — |